Delivery Order SPE2DR25D3003-SPE2DR26F5QH9
- Not listed
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,385.42 on August 19, 2025, for the supply of Insulin Aspart 100 Unit/mL vials (10mL). This firm fixed-price delivery order, with an ultimate completion date of August 20, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The award was made through competitive procurement with no set-aside designation. The place of...
- The Defense Logistics Agency awarded a $4,196.47 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Insulin Aspart 100 Unit/mL vials (10mL) on July 31, 2025, with an ultimate completion date of August 1, 2025. This non-set-aside, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Insulin Aspart 100 Unit/mL vials (10 mL) with a firm fixed price of $3,831.58. The contract was competitively awarded without set-asides and carries an ultimate completion date of September 9, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,194.80 to AmerisourceBergen Drug Corp for the supply of Insulin Aspart 100 Unit/mL vials (10mL) under a firm fixed-price contract. The award, issued on September 19, 2025, with an ultimate completion date of September 22, 2025, represents a competitively awarded non-set-aside procurement. Performance of this delivery order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency has awarded a delivery order valued at $2,671.90 to AmerisourceBergen Drug Corp for the supply of Insulin Aspart 100 Unit/ML in 10 ML vials. This firm fixed price delivery order, issued on December 5, 2025, with an ultimate completion date of December 8, 2025, represents a routine pharmaceutical procurement under the company's existing contract vehicle with DLA. The award is unset-aside and competitively awarded, reflecting AmerisourceBergen's established...
- The Defense Logistics Agency awarded a delivery order valued at $1,416.40 to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Insulin Aspart 100 Unit/mL in 10mL vials. This is a firm fixed-price delivery order with an ultimate completion date of December 1, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued as a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,699.68 to AmerisourceBergen Drug Corp for the supply of Insulin Aspart 100 Unit/mL in 10mL vials. This non-competitive, firm fixed price delivery order was awarded on December 1, 2025, with an ultimate completion date of December 2, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a child delivery order issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Insulin Aspart 100 Unit/mL vials (10 mL) with a ceiling value of $1,463.20. This is a firm fixed price delivery order with an ultimate completion date of October 24, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a $1,692.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Insulin Aspart 100 Unit/mL vials (10mL) with a completion date of September 18, 2025. This non-set-aside delivery order was competitively awarded and represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with DLA. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Insulin Aspart 100 Unit/ML pen 3ML under a firm fixed price contract with a ceiling value of $4,145.26. The award was issued on August 26, 2025, with an ultimate completion date of August 27, 2025, and represents a non-set-aside competitive award. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery...
- SPE2DR25D3003Indefinite Delivery Contract
- SPE2DR25D3003-SPE2DR26F5QH9Delivery Order
The Defense Logistics Agency (DLA) awarded a $3,736.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Insulin Aspart 100 Unit/mL vials (10mL units), with a completion date of December 12, 2025. This non-set-aside competitive award represents a child order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania location, where the company maintains its corporate headquarters as a major pharmaceutical distributor serving federal military and veteran healthcare systems. AmerisourceBergen Drug Corp's DLA contract serves as a comprehensive pharmaceutical support vehicle enabling the supply of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs globally. The company's consistent receipt of competitively awarded delivery orders across varying values demonstrates its capacity to meet federal procurement standards. This insulin order supports the Defense Health Agency and broader military medical supply chain requirements, reflecting the company's critical role as a prime vendor in the federal pharmaceutical procurement landscape.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 12/10/25 |